Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System

R. K. Budhani, J. K. Struthers
R. K. Budhani
Department of Medical Microbiology, Manchester Royal Infirmary and the University of Manchester, Manchester M13 9WL, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. K. Struthers
Department of Medical Microbiology, Manchester Royal Infirmary and the University of Manchester, Manchester M13 9WL, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.42.10.2521
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The majority of clinical isolates of Moraxella catarrhalis produce β-lactamase. The role of this enzyme in the phenomenon of indirect pathogenicity, in which a true pathogen such as Streptococcus pneumoniae is protected from the action of certain β-lactam antibiotics, is well recognized. By using a simple continuous-culture biofilm system, it has been shown that the pneumococcus attains high titers in excess of 1012CFU/biofilm; furthermore, the penicillin-sensitive pneumococcus used remained susceptible to a range of β-lactam antibiotics in these biofilms (R. K. Budhani and J. K. Struthers, J. Antimicrob. Chemother. 40:601–602, 1997). This system was used to characterize the antibiotic susceptibility of this isolate when grown with β-lactamase-negative or -positive moraxellae. When grown with β-lactamase-producing moraxellae in the presence of either benzylpenicillin or amoxicillin, the pneumococcus was protected in the range of the antibiotic concentrations to which it would be considered resistant. With amoxicillin-clavulanic acid the titers of the two organisms collapsed at the antibiotic concentration at which moraxellae became susceptible. The levels of β-lactamase activity in cell-free supernatants of broth culture, in biofilm, and in biofilm effluent revealed distinct differences in this activity; levels in biofilm were significantly lower than those in broth culture supernatants. The system appears suitable for studying organisms under antibiotic stress and for investigating the interactions of bacteria under such conditions.

Moraxella catarrhalis is a gram-negative diplococcus which is often isolated from respiratory tract secretions sent to microbiology laboratories; a survey conducted in the United Kingdom in 1991 showed that M. catarrhalis was the third most common organism isolated after Streptococcus pneumoniae andHaemophilus influenzae (16). An important feature of M. catarrhalis is that at least 90% of isolates produce a β-lactamase with activity against β-lactams such as penicillin and the amino penicillins (7). Based on isoelectric focusing patterns, the β-lactamases of M. catarrhalis can be designated as BRO-1 or BRO-2. The former type is more common, and levels of expression of the BRO-1 enzyme are higher than those of BRO-2 (5, 7). While the self-protective role of the enzyme is evident, the phenomenon of indirect pathogenicity in mixed infections, in which a true pathogen such as a pneumococcus is also protected by the enzyme, is well recognized (1, 18). It is known that the sputa of patients being treated with penicillin, from which both pneumococci and β-lactamase-producing moraxellae have been isolated, do not contain detectable amounts of the antibiotic (18). This protective effect has been recently demonstrated in vivo, with a mouse model (10), but the details of this interaction in vitro have not been clearly defined. Kassim and Williams used broth cultures in their investigations and have demonstrated a degree of protection of pneumococci by β-lactamase-positive moraxellae in the presence of antibiotics such as penicillin (12, 13). This system was limited by the fact that it does not involve a continuous culture and thus variations in the growth rates of the organisms can occur.

A more reproducible and continuous culture system would be important in defining the relationship between S. pneumoniae andM. catarrhalis. The simple Sorbarod continuous-culture biofilm system appears ideal for such an investigation. We have shown recently that S. pneumoniae attains consistently high concentrations (>1012 CFU/biofilm) for a period of at least 96 h in Sorbarod filters (2); these filters consist of a concertina of cellulose fibers in a paper sleeve. Here we characterize the growth of pneumococci on these biofilms in the presence of β-lactamase-positive or β-lactamase-negative moraxellae and of different concentrations of three β-lactam antibiotics. The characteristics of the protective effect of moraxella BRO-1 β-lactamase in a biofilm system are described.

MATERIALS AND METHODS

Bacteria. S. pneumoniae ATCC 671310 and the clinical isolate (serotype 19) described previously were used (2). M. catarrhalis ATCC 25238 (β-lactamase negative), β-lactamase-positiveM. catarrhalis (BRO-1 β-lactamase), and penicillin-intermediate isolates of S. pneumoniae were obtained from departmental teaching stocks. Isolates of S. pneumoniae resistant to penicillin were obtained from the Antibiotic Reference Laboratory, Public Health Laboratory Service, Colindale, United Kingdom.

Antibiotics.The following antibiotics were used: benzylpenicillin (Britannia, Redhill, United Kingdom), amoxicillin and amoxicillin-clavulanic acid (SmithKline Beecham, Worthing, United Kingdom), vancomycin (Lilly, Basingstoke, United Kingdom), and aztreonam (Bristol-Myers Squibb, Hounslow, United Kingdom). The ratio of amoxicillin to clavulanic acid used was 5:1.

Tube MIC and MBC and the E test.Tube MIC and minimal-bactericidal-concentration (MBC) tests were done by a recognized procedure using brain heart infusion (BHI) broth (Oxoid, Unipath, Basingstoke, United Kingdom); the concentration of bacteria at the beginning of each experiment was approximately 105CFU/ml (11). The penicillin E test was performed with direct sensitivity test agar (Oxoid, Unipath), according to the manufacturer’s instructions (AB Biodisk, Solna, Sweden).

Sorbarod biofilms.The method described previously was used (2, 9, 14). For each experiment, 12 20- by 10-mm Sorbarod filters (Ilacon, Tonbridge, Kent, United Kingdom) were prepared in order to have a control antibiotic-free biofilm and enough biofilms to cover twofold dilutions of an antibiotic in concentrations ranging from 0.004 to 16 mg/liter. Individual filters were inoculated with 3 ml of an exponential-phase broth culture of an organism or with the same volume of both bacteria. For broth culture and the biofilm “feeding,” BHI was used. BHI was delivered at a rate of 0.1 ml/min by means of a 12-channel 205U peristaltic pump (Watson Marlow, Falmouth, United Kingdom). After 24 h, when steady-state growth had been obtained (2), individual biofilms were exposed to a single concentration of an antibiotic for 18 h, using the same broth (BHI) and flow rate. After this period, effluent was collected for 15 min in order to determine the concentration of planktonic bacteria, and the biofilm was then disintegrated in 5 ml of BHI broth with a vortex mixer and the titers of the bacteria were determined by a recognized method (11). All biofilm titers were multiplied by a factor of 6.57 to take into account the 5 ml of broth added and the volume of the filter itself (14). The titers of effluent and biofilm were determined in triplicate on Columbia blood agar (Oxoid). When titrating mixtures of the two organisms, Columbia blood agar containing 2 μg of vancomycin per ml or 10 μg of aztreonam per ml was used as the selective medium for M. catarrhalis orS. pneumoniae, respectively. The biofilm eradicating concentration (BEC), the lowest concentration of an antibiotic that eradicated the organisms from biofilm, was determined as described previously (2, 14).

In order to ensure that bacteria were not being killed by any β-lactam antibiotics during vortex mixing of the biofilm and the titration steps, a broad-spectrum β-lactamase preparation (Bacillus cereus β-lactamases I and II; Oxoid) was included at these stages in several experiments. The final concentration of the added β-lactamase was approximately 104 mU/ml.

Determination of moraxella β-lactamase activity.The method used was essentially the same as that described previously (3, 12). Supernatants of broth culture, biofilm after vortex mixing, and biofilm effluent were collected following centrifugation at 2,000 × g for 10 min. One-hundred-microliter volumes of the supernatant were mixed with equal volumes of nitrocefin (Oxoid), at a concentration of 100 μg/ml, in the wells of 96-well microtiter plates (Sterilin, Stone, Staffordshire, United Kingdom). Plates were incubated in the dark at 37°C for 30 min and were then read immediately at 492 nm in a Multiscan MCC/340 MKII plate reader. Readings were converted to milliunits per milliliter by using a standard curve prepared under the same conditions with B. cereus type I β-lactamase (Sigma, Poole, Dorset, United Kingdom) of known specific activity. Readings were converted to nanomoles of nitrocefin hydrolyzed per minute.

RESULTS

The results of the tube MIC and MBC tests, E test, and BEC test for the various isolates of S. pneumoniae are shown in Table 1. Using the tube MIC and MBC test and E test as controls, it is evident that the BECs of the various penicillin-sensitive, -intermediate, and -resistant isolates of pneumococcus tested showed that irrespective of penicillin susceptibility, there was no protection of the organism in this biofilm mode of growth. We were therefore confident that any survival of the pneumococcal isolate serotype 19 in the presence of antibiotic would be due to M. catarrhalis BRO-1 β-lactamase.

View this table:
  • View inline
  • View popup
Table 1.

Susceptibilities of six isolates of S. pneumoniae to benzylpenicillina

In order to determine if the initial biofilm inoculum concentrations had any effect on the ability of the two organisms to establish themselves together on a biofilm, the following experiment was done. Undiluted broth cultures of either S. pneumoniae or M. catarrhalis were mixed with a 10-fold dilution of the other organism; this mixture was used to inoculate a Sorbarod filter. After 24 h, effluent was collected, the biofilm was sacrificed, and the titers of the two organisms were determined on the selective media. The results in Table 2 show that after the 24-h period, the two organisms achieved similar titers within the biofilms, on the order of 1013 CFU/biofilm. Fluctuations in the titers of the organisms in the biofilm effluent were noted; on occasion, they were in excess of 10-fold, as shown in Table 2. It is important to note that the effluent titers were at least 4 log values lower than those in the biofilms.

View this table:
  • View inline
  • View popup
Table 2.

Biofilm and effluent organism titers in mixed Sorbarod biofilm cultures of S. pneumoniae serotype 19 and M. catarrhalis ATCC 25238

The results of the experiments combining the pneumococcus with either β-lactamase-negative or -positive M. catarrhalisin the presence of various concentrations of antibiotics are shown in Fig. 1. Clearly, the β-lactamase-negative moraxella was unable to protect the pneumococcus; the BEC obtained for the antibiotics used with serotype 19 was essentially the same as that shown in Table 1. In contrast, the presence of β-lactamase-positive moraxellae had a definite protective effect. In repeated experiments with benzylpenicillin and amoxicillin, there was an approximate 3- to 4-log value collapse of the pneumococcal titer at concentrations between 0.064 and 2.0 mg/liter. The surviving pneumococcal population, on the order of 1010CFU/biofilm, was protected at concentrations of both penicillin and amoxicillin of above 2 mg/liter. With amoxicillin-clavulanic acid, the titer of the pneumococcus was essentially maintained until the collapse of the moraxella population at 1 to 2 mg/liter; in these experiments, the pneumococcal population was then eliminated. Despite the massive collapse in the moraxella population in the presence of amoxicillin-clavulanic acid, a surviving population of this organism, with a biofilm titer in the region of 107 CFU/filter, was maintained up to at least 16 mg/liter (data not shown). The results of the pneumococcal experiments with benzylpenicillin and amoxicillin in which B. cereus β-lactamase was included in biofilm vortex mixing and in all the subsequent titration steps are shown in Tables 3 and4. These results show that the addition of the B. cereus β-lactamase did not significantly affect the titers.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Biofilm and effluent titers of S. pneumoniae(• and ○, respectively) and M. catarrhalis (▴ and ▵, respectively) (β-lactamase negative [a, c, and e] and β-lactamase positive [BRO1] [b, d, and f]) grown together on Sorbarod biofilms in the presence of benzylpenicillin (a and b), amoxicillin (c and d), and amoxicillin-clavulanic acid (e and f). Individual filters were inoculated with mixtures of the two organisms and, after 24 h, were exposed to a single concentration of the antibiotic for 18 h. Effluent was collected for 15 min, the biofilm was sacrificed, and the titers of pneumococci and moraxellae were determined on selective agar. Titers in biofilm are expressed as total recoverable CFU per biofilm. Titers in effluent are expressed as CFU per milliliter.

View this table:
  • View inline
  • View popup
Table 3.

Pneumococcal titers from biofilms and biofilm effluents after vortex mixing and subsequent titration in the presence and absence ofB. cereus β-lactamasea

View this table:
  • View inline
  • View popup
Table 4.

Pneumococcal titers from biofilms and biofilm effluents after vortex mixing and subsequent titration in the presence and absence ofB. cereus β-lactamasea

The β-lactamase activities in biofilm and effluent supernatants are shown in Fig. 2. For penicillin there was a random level of β-lactamase activity, but for both amoxicillin and amoxicillin-clavulanic acid an increase in the biofilm β-lactamase activity was noted at antibiotic concentrations between 0.125 and 8 mg/liter. This increase was matched to a lesser extent in the biofilm effluents. An increase in cell-free β-lactamase activity was also observed, for example, when moraxella strain BRO1 alone was exposed to amoxicillin under the same biofilm conditions (data not shown). It was considered important to determine the level of cell-free β-lactamase activity during the growth of strain BRO1 in broth culture and during the establishment of the organism on biofilms, in order to determine the relative degree of β-lactamase activity under the two different growth conditions. The results in Fig.3 show that β-lactamase activity was always lower in the biofilms. Even at the very high organism numbers achieved in biofilm after 24 h, the rate of activity was always lower than that of the broth culture cell-free fraction.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

β-Lactamase activities in the supernatant fractions of biofilm (■) and effluent (⧫) preparations (Fig. 1) with the mixtures of the pneumococcus and strain BRO1. The supernatant was obtained by centrifuging both biofilms after vortex mixing and effluent at 3,500 rpm for 10 min. β-Lactamase activity (expressed as nanomoles of nitrocefin hydrolyzed per minute) was determined as described in the text. (a, benzylpenicillin; b, amoxicillin; c, amoxicillin-clavulanic acid).

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

(a) Titers of strain BRO1 grown in broth culture and biofilm (plus biofilm effluent) collected at various times after inoculation. Titers in biofilm are expressed as recoverable CFU per biofilm; titers in effluent are expressed as CFU per milliliter. (b) β-Lactamase activity (nanomoles of nitrocefin hydrolyzed per minute) in the supernatants of the same specimens. ■, broth; ▴, biofilm; ▵, effluent.

DISCUSSION

The work presented here shows that the Sorbarod continuous-culture biofilm system is useful for studying the effect of antibiotics on organisms grown together. By defining the system with strains of pneumococcus with different susceptibilities to penicillin we were able to show that this biofilm mode of growth did not provide any protection for this organism. This is in contrast to the results of previous studies, on the basis of which the biofilm mode of growth has been considered protective for microorganisms (4, 8, 15). When the two bacteria were grown together on a biofilm, in the absence of antibiotics, they reached and maintained the same titers as the organisms grown separately, that is, in excess of 1012CFU/biofilm. We were therefore confident that in the absence of antibiotics, neither organism could establish and maintain itself on biofilm to the detriment of the other. The BEC for the pneumococcus in the presence of the β-lactamase-negative moraxella was the same as that published previously (2). When the pneumococcus was grown with the β-lactamase-positive moraxella in the presence of benzylpenicillin or amoxicillin, an approximately 4-log value collapse of the pneumococcus population was observed. The surviving pneumococcal population, on the order of 1010CFU/biofilm, was protected in the antibiotic concentration at which the organism is considered to be highly resistant to penicillin, that is, in excess of 2 mg/liter (6). With amoxicillin-clavulanic acid the protective effect existed up to the collapse of the moraxella population at concentrations of 1 to 2 mg/liter and above, showing the positive effect of clavulanic acid in abolishing the indirect pathogenic effect of β-lactamase-producing M. catarrhalis; however, the pneumococcus would still be regarded as resistant according to the criteria used (6). Thus, there appeared to be two identifiable pneumococcal populations observed in the experiments with penicillin and amoxicillin, one in the sensitive to intermediate range and another that remained resistant to these antibiotics due to the protective effect of the moraxella β-lactamase.

The β-lactamase levels in biofilm and effluent supernatants (Fig. 2) showed that there was no discernible difference across the range of penicillin concentrations used. However, peaks were noted in the biofilm supernatants in the amoxicillin and amoxicillin-clavulanic acid experiments; a rise in β-lactamase activity in the effluents was less distinct. This rise in the cell-free β-lactamase activity in biofilm may represent a subpopulation of strain BRO1 that undergoes lysis as a result of antibiotic activity, releasing the enzyme into the cell-free environment. Similar results were obtained with strain BRO1 alone when it was exposed to amoxicillin under the same biofilm conditions (data not shown). Figure 3 shows the titers of bacteria and β-lactamase levels in cell-free supernatants both of broth culture and during the establishment of strain BRO1 on biofilms. Despite the significantly higher bacterial titer in biofilm than in broth, the level of enzyme activity in biofilm supernatants was always lower. Comparing the maximum broth titer at 18 h with the maximum biofilm titer at 48 h and the enzyme activities at these times showed that the relative activity of cell-free enzyme in biofilm was on the order of 200-fold lower (Fig. 3). The population of moraxellae collected over 15 min in the effluent must reflect the presence of free planktonic bacteria which are eluted from the biofilm. As shown in Fig.3, this effluent population is at least 3 log values less than the equivalent established biofilm population of the moraxella. Examining the levels of cell-free enzyme activity in the established biofilm and effluent populations showed that, based on relative organism numbers, the activity in biofilm is at least 3 to 4 log values lower than that in the effluent. Production of β-lactamase byM. catarrhalis is considered to be constitutive (17); however, some regulatory system may exist at the high organism numbers achieved in this biofilm system.

Of particular interest in this study was the absence of strain BRO1 bacteria in certain effluents of mixtures of the two organisms. While this was seen on occasion when the pneumococcus and the moraxella were grown on Sorbarod filters in the absence of antibiotics, this phenomenon was regularly observed in mixed infections in the presence of lower concentrations of the three antibiotics used. This is evident in the graphs presented in Fig. 1, which show that the moraxella was absent from 13 of 15 effluents at antibiotic concentrations below 0.25 mg/liter. This phenomenon was observed in repeated experiments with penicillin (two of three experiments), amoxicillin (two of three experiments), and amoxicillin-clavulanic acid (two of two experiments). The effluent curves of strain BRO1 in Fig. 1 show that when it is present, titers were on the order of 106 to 108CFU/ml, at least 4 log values lower than the titer of the equivalent biofilm population at a particular antibiotic concentration. Despite this significant difference in the biofilm and effluent moraxella titers, the repeated absence of the β-lactamase-positive moraxella could indicate a type of interspecies signalling system whereby a pneumococcus population stressed by an antibiotic attempts to keep an ally in the biofilm environment itself. The indirect pathogenic role of β-lactamase-producing M. catarrhalis that has been proposed (1, 18) may not therefore involve a passive interaction. The Sorbarod biofilm system thus appears to have a role in elucidating the interaction between bacteria when they are exposed to antibiotics.

ACKNOWLEDGMENTS

R. K. Budhani is a predoctoral student funded by a scholarship from the Shah Latif University, Khairpur, Pakistan.

We thank A. Johnson of the Public Health Laboratory Service for providing the resistant pneumococcal isolates.

FOOTNOTES

    • Received 19 December 1997.
    • Returned for modification 1 April 1998.
    • Accepted 13 July 1998.
  • Copyright © 1998 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Brook I.
    The concept of indirect pathogenicity by β-lactamase production, especially in ear, nose and throat infection. J. Antimicrob. Chemother. 24 1989 63 72
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Budhani R. K.,
    2. Struthers J. K.
    The use of Sorbarod biofilms to determine the antimicrobial susceptibilities of a strain of Streptococcus pneumoniae. J. Antimicrob. Chemother. 40 1997 601 602
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Dragicevic P.,
    2. Hill S. L.,
    3. Burnett D.,
    4. Merrikin D.,
    5. Stockley R. A.
    Activities and sources of β-lactamase in sputum from patients with bronchiectasis. J. Clin. Microbiol. 27 1989 1055 1061
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Duguid I. G.,
    2. Evans E.,
    3. Brown M. R. W.,
    4. Gilbert P.
    Effect of biofilm culture on the susceptibility of Staphylococcus epidermidis to tobramycin. J. Antimicrob. Chemother. 30 1992 803 810
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Farmer T.,
    2. Reading C.
    β-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21 1982 506 508
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Friedland I. R.,
    2. McCracken G. H.
    Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331 1994 377 382
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Fung C. P.,
    2. Yeo S. F.,
    3. Livermore D. M.
    Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattern. J. Antimicrob. Chemother. 33 1994 215 222
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Gander S.
    Bacterial biofilms: resistance to antimicrobial agents. J. Antimicrob. Chemother. 37 1996 1047 1050
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Hodgson A. E.,
    2. Nelson S. M.,
    3. Brown M. R. W.,
    4. Gilbert P.
    A simple in-vitro model for growth control of bacterial biofilms. J. Appl. Bacteriol. 79 1995 87 93
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Hol H.,
    2. van Dijke E. E. M.,
    3. Verduin C. M.,
    4. Verhoef J.,
    5. van Dijk H.
    Experimental evidence for Moraxella-induced neutralisation in pneumococcal pneumonia. J. Infect. Dis. 170 1994 1613 1616
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Holt A.,
    2. Brown D.
    Antimicrobial susceptibility testing Medical bacteriology, a practical approach. Hawkey P. M., Lewis D. A. 1989 167 194 IRL Press Oxford, United Kingdom
  12. 12.↵
    1. Kassim M.
    The in-vitro studies of Branhamella catarrhalis BRO1: epidemiology and antimicrobial susceptibilities with emphasis on the importance of the β-lactamase enzyme. Ph.D. thesis. 1994 Queen Mary’s College, University of London London, United Kingdom
  13. 13.↵
    1. Kassim M.,
    2. Williams J. D.
    In-vitro studies of the indirect pathogenic role of Branhamella (Moraxella) catarrhalis BRO1, abstr. 5. Forum of Evaluation of Anti-Infective Therapy, Antibiotics and the Respiratory Tract 1992
  14. 14.↵
    1. Muli F.,
    2. Struthers J. K.
    Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. Antimicrob. Agents Chemother. 42 1998 1428 1432
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Nichols W. W.
    Biofilms, antibiotics and penetration. Rev. Med. Microbiol. 2 1991 177 181
    OpenUrl
  16. 16.↵
    1. Powell M.,
    2. Mcvey D.,
    3. Kassim M. H.,
    4. Chen H. Y.,
    5. Williams J. D.
    Antimicrobial susceptibility of Streptococcus pneumoniae,Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the United Kingdom from sputa. J. Antimicrob. Chemother. 28 1991 249 259
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Stobberingh E. E.,
    2. Van Eck H. J.,
    3. Houben A. W.,
    4. Van Boven C. P. A.
    Analysis of the relationship between ampicillin resistance and β-lactamase production in Branhamella catarrhalis. Drugs 31 1986 23 27
    OpenUrl
  18. 18.↵
    1. Wardle J. R.
    Branhamella catarrhalis as an indirect pathogen. Drugs 31 1986 93 96
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System
R. K. Budhani, J. K. Struthers
Antimicrobial Agents and Chemotherapy Oct 1998, 42 (10) 2521-2526; DOI: 10.1128/AAC.42.10.2521

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System
R. K. Budhani, J. K. Struthers
Antimicrobial Agents and Chemotherapy Oct 1998, 42 (10) 2521-2526; DOI: 10.1128/AAC.42.10.2521
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

biofilms
Moraxella (Branhamella) catarrhalis
Streptococcus pneumoniae
beta-lactamases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596